Abstract | OBJECTIVE: METHODS: RESULTS: All the four patients had a smooth operation, an uneventful early postoperative recovery and good living quality. The patient with liver metastases from pancreatic endocrine tumor had liver tumor recurrence at four and a half years after the transplantation, and then underwent left lateral hepatic lobectomy, without any recurrence until now. The patient with liver metastases from rectal endocrine tumor had right renal and pelvic tumor metastasis at 16 months after the operation, and died of tumor recurrence 5 years after the liver transplantation. The patient with liver metastases from gastric stromal tumor had extensive pelvic metastases at five and a half months after the transplantation, and survived with tumor for 4 years and 6 months after the operation. The patient with liver metastases from colorectal carcinoma had extensive bilateral lung metastases at 3 months after the transplantation and died one and a half years after the operation. CONCLUSION: For well-differentiated unresectable metastatic liver cancers, liver transplantation may serve as a treatment option and better treatment results can be achieved for some highly selected patients.
|
Authors | L J Wang, Y M Zhang, Y L Deng, H Zheng, C Pan, Z Y Shen |
Journal | Zhonghua zhong liu za zhi [Chinese journal of oncology]
(Zhonghua Zhong Liu Za Zhi)
Vol. 38
Issue 5
Pg. 381-4
(May 23 2016)
ISSN: 0253-3766 [Print] China |
PMID | 27188613
(Publication Type: Journal Article)
|
Topics |
- Colorectal Neoplasms
(pathology)
- Feasibility Studies
- Gastrointestinal Stromal Tumors
(secondary, surgery)
- Hepatectomy
(methods)
- Humans
- Liver Neoplasms
(secondary, surgery)
- Liver Transplantation
- Lung Neoplasms
(secondary)
- Neoplasm Recurrence, Local
- Pancreatic Neoplasms
(pathology)
- Rectal Neoplasms
(pathology)
- Treatment Outcome
|